Cellular therapies

‘Living’ anticancer medicines: has a new era started?

The benefits of adoptive T-cell therapy—where T-cells are given to induce a specific immune response—are moving closer to reality for patients with solid tumours. Studies presented at ESMO Congress 2019 over the past few days…

Read More